[go: up one dir, main page]

MX2021000344A - Metodo para preparar y suministrar soluciones de ovoquistes. - Google Patents

Metodo para preparar y suministrar soluciones de ovoquistes.

Info

Publication number
MX2021000344A
MX2021000344A MX2021000344A MX2021000344A MX2021000344A MX 2021000344 A MX2021000344 A MX 2021000344A MX 2021000344 A MX2021000344 A MX 2021000344A MX 2021000344 A MX2021000344 A MX 2021000344A MX 2021000344 A MX2021000344 A MX 2021000344A
Authority
MX
Mexico
Prior art keywords
oocyst
solution
delivering
processing chamber
preparing
Prior art date
Application number
MX2021000344A
Other languages
English (en)
Inventor
Ramin Karimpour
James Hutchins
Elizabeth Turpin
Stephen Wolfe
Joshua Steven Goff
Original Assignee
Applied Lifesciences And Systems Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Lifesciences And Systems Llc filed Critical Applied Lifesciences And Systems Llc
Publication of MX2021000344A publication Critical patent/MX2021000344A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D1/00—Surgical instruments for veterinary use
    • A61D1/02—Trocars or cannulas for teats; Vaccination appliances
    • A61D1/025—Vaccination appliances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/001—Details of inhalators; Constructional features thereof with means for agitating the medicament using ultrasonic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/30—Vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2250/00—Specially adapted for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Chemistry (AREA)
  • Colloid Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente descripción proporciona sistemas y métodos para alterar la membrana exterior de un ovoquiste en solución y suministrar la solución a un animal. El sistema incluye un recipiente que contiene ovoquistes intactos en solución, una cámara de procesamiento de ovoquistes y una salida de suministro. Los ovoquistes intactos se mueven del recipiente a través de la cámara de procesamiento y una porción de las membranas del ovoquiste se alteran liberando esporoquistes, la solución resultante se mueve de la cámara de procesamiento a la salida de suministro donde la solución se suministra a un animal. También se proporcionan métodos de vacunación, incluida vacunación contra una infección por Eimeria.
MX2021000344A 2018-07-10 2019-07-10 Metodo para preparar y suministrar soluciones de ovoquistes. MX2021000344A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862696261P 2018-07-10 2018-07-10
PCT/US2019/041178 WO2020018325A1 (en) 2018-07-10 2019-07-10 Method of preparing and delivering oocyst solutions

Publications (1)

Publication Number Publication Date
MX2021000344A true MX2021000344A (es) 2021-03-25

Family

ID=67480312

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2021000344A MX2021000344A (es) 2018-07-10 2019-07-10 Metodo para preparar y suministrar soluciones de ovoquistes.
MX2021000352A MX2021000352A (es) 2018-07-10 2019-07-10 Sistemas y metodos de preparacion y administracion de geles.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021000352A MX2021000352A (es) 2018-07-10 2019-07-10 Sistemas y metodos de preparacion y administracion de geles.

Country Status (12)

Country Link
US (2) US20210138165A1 (es)
EP (2) EP3813875A1 (es)
JP (3) JP2021531262A (es)
KR (2) KR20210035778A (es)
CN (2) CN112469437A (es)
AU (2) AU2019301657A1 (es)
BR (2) BR112021000162A2 (es)
CA (2) CA3104875A1 (es)
IL (2) IL278389B2 (es)
MX (2) MX2021000344A (es)
WO (2) WO2020018325A1 (es)
ZA (2) ZA202007506B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3300690T3 (pl) * 2008-01-31 2019-11-29 Zoetis Services Llc System do szczepienia trzody chlewnej
IT202000007816A1 (it) * 2020-04-14 2021-10-14 Adamas Biotech S R L Presidio medico inibitore di coronavirus
TWI776389B (zh) * 2021-02-09 2022-09-01 元樟生物科技股份有限公司 水凝膠的噴劑裝置及製作方法
US11596913B2 (en) * 2021-07-16 2023-03-07 Clearh2O, Inc. Methods of high throughput hydrocolloid bead production and apparatuses thereof
US12350641B2 (en) 2021-07-16 2025-07-08 Clearh2O, Inc. Methods of high throughput hydrocolloid bead production and apparatuses thereof
CN114146169B (zh) * 2021-12-28 2023-08-25 佛山市正典生物技术有限公司 鸡球虫喷滴免疫用载体组合物及使用方法和鸡球虫喷滴免疫组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040234A1 (en) * 1995-06-07 1996-12-19 Pfizer Inc. In ovo vaccination against coccidiosis
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
WO1996040233A1 (en) * 1995-06-07 1996-12-19 Pfizer Inc. In ovo vaccination against coccidiosis
JPH11178910A (ja) * 1997-10-16 1999-07-06 Sekisui Chem Co Ltd 創傷被覆材及びその塗布方法
AUPP268398A0 (en) * 1998-03-30 1998-04-23 Eimeria Pty Limited Vaccination modalitites
WO2001034187A2 (en) * 1999-11-08 2001-05-17 Novus International, Inc. Preparation and method for prevention of coccidiosis
US7354593B2 (en) * 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
WO2004052378A1 (ja) * 2002-12-10 2004-06-24 Masaya Tanaka 皮膚外用材及びそれを用いた外用止痒剤、しわ取り具
CA2416726A1 (en) * 2003-01-20 2004-07-20 Eng-Hong Lee Soft gel vaccine delivery system for treating poultry
MX2007012784A (es) * 2005-04-15 2008-01-11 Univ Georgia Res Found Vacuna coccidial y metodos para elaborarla y usarla.
CN101184500A (zh) * 2005-04-15 2008-05-21 梅瑞尔有限公司 球虫疫苗及其制备和使用方法
US20080006799A1 (en) * 2006-07-06 2008-01-10 Bob Fowle Method for producing a fire retardant gel and product made thereby
WO2008076548A2 (en) 2006-11-09 2008-06-26 Contract Medical International Gmbh Cardiovascular procedures
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
US20080194006A1 (en) 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
NZ585407A (en) * 2007-11-14 2011-10-28 Univ Queensland Device and method for preparing microparticles
AR071917A1 (es) * 2008-05-29 2010-07-21 Intervet Int Bv Vacunas contra la coccidiosis
WO2010037027A2 (en) * 2008-09-26 2010-04-01 Auburn University Immunization of avians by mucosal administration of non-replicating vectored vaccines
US20110081701A1 (en) * 2009-10-02 2011-04-07 Timothy Sargeant Surgical compositions
GB201305231D0 (en) * 2013-03-21 2013-05-01 Isis Innovation Method of Manufacture
KR20160118317A (ko) 2014-02-03 2016-10-11 아푸라노 파마수티컬스 게엠베하 천연 재료의 나노현탁액 및 그의 제조 방법
WO2017030876A1 (en) * 2015-08-14 2017-02-23 Clearh2O, Inc. High throughput process for delivering semi-firm gel for poultry
IL283300B2 (en) 2015-11-13 2024-04-01 Applied Lifesciences And Systems Llc Automatic system for injecting a substance into an animal

Also Published As

Publication number Publication date
IL278389B1 (en) 2023-06-01
BR112021000267A2 (pt) 2021-04-06
WO2020018325A1 (en) 2020-01-23
IL278390B2 (en) 2023-10-01
EP3813875A1 (en) 2021-05-05
IL278389A (es) 2020-12-31
IL278389B2 (en) 2023-10-01
ZA202007505B (en) 2022-11-30
JP7422126B2 (ja) 2024-01-25
IL278390B1 (en) 2023-06-01
WO2020014367A1 (en) 2020-01-16
ZA202007506B (en) 2023-07-26
CN112469438A (zh) 2021-03-09
AU2019308513A1 (en) 2021-03-04
US20210138106A1 (en) 2021-05-13
CA3104875A1 (en) 2020-01-16
IL278390A (es) 2020-12-31
JP2025026863A (ja) 2025-02-26
KR20210035778A (ko) 2021-04-01
JP2021530493A (ja) 2021-11-11
BR112021000162A2 (pt) 2021-04-06
AU2019301657A1 (en) 2021-03-04
US20210138165A1 (en) 2021-05-13
CA3104872A1 (en) 2020-01-23
EP3813876A1 (en) 2021-05-05
MX2021000352A (es) 2021-03-25
CN112469437A (zh) 2021-03-09
KR20210035087A (ko) 2021-03-31
JP2021531262A (ja) 2021-11-18

Similar Documents

Publication Publication Date Title
MX2021000344A (es) Metodo para preparar y suministrar soluciones de ovoquistes.
WO2018011805A3 (en) Systems and methods for growing cells in vitro
Greyer et al. T cell help amplifies innate signals in CD8+ DCs for optimal CD8+ T cell priming
MX2020008660A (es) Modulo de sistema de deteccion de dosis para dispositivo de administracion de medicamento.
IL277025B1 (en) Methods for improving the differentiation of stem cells into beta cells
SA518392270B1 (ar) إنتاج ملاط ثلجي طبي وأنظمة توصيل وطرق
MY182497A (en) Ocular implant delivery device and method
WO2017214327A3 (en) Non-integrating viral delivery system and methods related thereto
EP3284400A3 (en) Breathprint sensor systems, smart inhalers and methods for personal identification
MX367350B (es) Sistema y metodo para el tratamiento continuo de solidos a presion no atmosferica.
MX2017008659A (es) Reactor biopelicula de membrana aireada.
EP4234569A3 (en) Method and use for continuously inactivating a virus during manufacture of a biological product
MX2018010288A (es) Sistema de transposon y metodos de uso.
MX2017016095A (es) Aparatos, metodos y sistemas para cultivar un microcultivo que involucra un dispositivo de acoplamiento flotante.
EP4218877A3 (en) Adaptor for respiratory assistance systems
WO2016159784A9 (en) Adaptor for respiratory assistance systems
EP4483909A3 (en) Apparatus and method for sterilization of an article
WO2021222476A3 (en) High efficiency gene delivery system
MX2024008995A (es) Sistemas y metodos para la preparacion de productos derivados de vegetales que utilizan tecnicas de osmosis.
GB2558162A8 (en) Toroidal bed reactor
WO2020084295A3 (en) Gut bacteria derived microvesicles for vaccine delivery
MX2024004298A (es) Sistema para inyección de órganos.
EP4520312A3 (en) Therapeutic gas infused cosmetic and methods of infusion
MX2022012109A (es) Uso de la fitasa para obtener alimentos mejorados.
Mazzocco et al. Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma